BioMarin to Host Second Quarter 2026 Financial Results Conference Call and Webcast on Thursday, August 6, 2026, at 4:30pm ET

Rhea-AI Summary

BioMarin (NASDAQ: BMRN) announced that President and CEO Alexander Hardy will host a conference call and webcast on Thursday, August 6, 2026, at 4:30 p.m. ET to discuss second quarter 2026 financial results and provide a general business update.

Investors can join via phone using conference ID 3551298 or access a live audio webcast through the investor section of the BioMarin website. A replay will be available for one week.

Market Context

1.76% was the average 24-hour move across five tag-matched earnings-date announcements. Against that...

Analysis

1.76% was the average 24-hour move across five tag-matched earnings-date announcements. Against that record, this notice established an August 6 call but no results; the peer snapshot was mostly lower, and recent insider activity was Net Selling.

Key Figures

Results period: Second quarter 2026 Conference call date: August 6, 2026 Conference call time: 4:30 p.m. ET

3 metrics

Results period Second quarter 2026 Financial results to be discussed

Conference call date August 6, 2026 Scheduled webcast and conference call

Conference call time 4:30 p.m. ET Scheduled start time

Previous Conferences,earnings date Reports

5 past events · Latest: Apr 27 (Neutral)

Same Type Pattern 5 events

Date	Event	Sentiment	24h Move	Catalyst
Apr 27	Q1 earnings call	Neutral	+1.2%	Scheduled conference call to discuss quarterly financial results and provide business update.
Feb 17	Q4 earnings call	Neutral	+0.1%	Scheduled conference call covering fourth-quarter and full-year financial results.
Oct 22	Q3 earnings call	Neutral	+2.2%	Scheduled conference call to discuss third-quarter financial results and business updates.
Jul 22	Q2 earnings call	Neutral	+4.7%	Scheduled second-quarter financial performance discussion and business update.
Apr 17	Q1 earnings call	Neutral	+0.6%	Scheduled conference call to discuss first-quarter financial performance and business update.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

All five tag-matched earnings-date announcements had positive 24-hour reactions, averaging 1.76%.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SAN RAFAEL, Calif., July 30, 2026 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Alexander Hardy, President and Chief Executive Officer of BioMarin, will host a conference call and webcast on Thursday, August 6, 2026, at 4:30 p.m. ET to discuss second quarter 2026 financial results and provide a general business update.

Dial-in Number 
U.S. / Canada Dial-in Number: 800-715-9871
International Dial-in Number: 646-307-1963
Conference Call ID: 3551298 

U.S. / Canada Replay Dial-in Number: 800-770-2030
International Replay Dial-in Number: 609-800-9909
Playback ID: 3551298 

Interested parties may access a live audio webcast of the conference call via the investor section of the BioMarin website, https://investors.biomarin.com/. A replay of the call will be archived on the site for one week following the call.

About BioMarin
BioMarin is a leading, global rare disease biotechnology company focused on delivering medicines for people living with genetically defined conditions. Founded in 1997, the San Rafael, California-based company has a proven track record of innovation, with nine commercial therapies and a strong clinical and preclinical pipeline. Using a distinctive approach to drug discovery and development, BioMarin seeks to unleash the full potential of genetic science by pursuing category-defining medicines that have a profound impact on patients. To learn more, please visit www.biomarin.com. 

Contacts:
Investors	Media
Traci McCarty	Marni Kottle
BioMarin Pharmaceutical Inc.	BioMarin Pharmaceutical Inc.
(415) 455-7558	(650) 374-2803

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/biomarin-to-host-second-quarter-2026-financial-results-conference-call-and-webcast-on-thursday-august-6-2026-at-430pm-et-302838363.html

SOURCE BioMarin Pharmaceutical Inc.

FAQ

When is BioMarin (BMRN) reporting its second quarter 2026 financial results?

BioMarin will discuss its second quarter 2026 financial results on August 6, 2026, at 4:30 p.m. ET. According to BioMarin, the event includes a financial review and a general business update hosted by President and CEO Alexander Hardy.

How can investors access the BioMarin (BMRN) Q2 2026 earnings conference call?

Investors can access the BioMarin Q2 2026 call by phone or webcast. According to BioMarin, a live audio webcast is available via the investor section of its website, and telephone dial-in numbers are provided for U.S., Canada, and international participants.

What are the dial-in numbers for the BioMarin (BMRN) August 6, 2026 earnings call?

U.S./Canada participants can dial 800-715-9871; international callers can dial 646-307-1963. According to BioMarin, the conference call ID is 3551298, which callers must enter to join the second quarter 2026 financial results discussion.

Will there be a replay of the BioMarin (BMRN) Q2 2026 earnings webcast?

Yes, a replay of the BioMarin Q2 2026 call will be available for one week. According to BioMarin, the replay will be archived on its investor website, with separate U.S., Canada, and international replay dial-in numbers and playback ID 3551298.

Who will host the BioMarin (BMRN) second quarter 2026 earnings call and what will be covered?

Alexander Hardy, BioMarin’s President and CEO, will host the Q2 2026 earnings call. According to BioMarin, the call will review second quarter 2026 financial results and provide a general business update for investors and other interested parties.